Trials / Completed
CompletedNCT04433754
The Development of Pancreatic Injury in the Course of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Pancreatic Injury in Patients With COVID-19 Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (actual)
- Sponsor
- Uşak University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Although COVID-19 disease due to Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the respiratory tract, heart and coagulation system, symptoms of gastrointestinal system involvement such as abdominal pain, nausea, vomiting and diarrhea are also common. In this study, it was aimed retrospective analysis of clinical and laboratory data of patients who developed pancreatic injury in the course of COVID 19 disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | biochemical analysis | cRP, d-dimer levels and lymphocyte counts will be compared |
Timeline
- Start date
- 2020-03-01
- Primary completion
- 2020-06-11
- Completion
- 2020-06-12
- First posted
- 2020-06-16
- Last updated
- 2020-06-16
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT04433754. Inclusion in this directory is not an endorsement.